Rockefeller Capital Management
PRME icon

Rockefeller Capital Management’s Prime Medicine PRME Stock Holding History

Rockefeller Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Sell
90,735
-666
-0.7% -$2.21K ﹤0.01% 2295
2026
Q1 		$318K Sell
91,401
-29,990
-25% -$114K ﹤0.01% 2226
2025
Q4 		$421K Buy
121,391
+120,252
+10,558% +$535K ﹤0.01% 1995
2025
Q3 		$6.31K Buy
+1,139
New +$4.63K ﹤0.01% 3807

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Rockefeller Capital Management's PRME Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Prime Medicine (PRME) stake by 0.73% in Q2 2026, selling an estimated $2.21K and leaving 90,735 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

Rockefeller Capital Management first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. The position peaked at $421K in Q4 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Rockefeller Capital Management held 90,735 shares of Prime Medicine worth $335K as of Q2 2026.
  • Rockefeller Capital Management sold 666 Prime Medicine shares in Q2 2026, an estimated $2.21K.
  • Prime Medicine made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2295 holding.
  • Rockefeller Capital Management first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Prime Medicine position peaked at $421K in Q4 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.